86 Views | 72 Downloads
Siva A. Vanapalli, Email: siva.vanapalli@ttu.edu
LL and KK performed NemaFlex and burrowing experiments. LL and HQ conducted immunostaining and captured images. LL and MN did statistical analysis and prepared figures. LL, HQ, CMRL, NJS, GMB and SAV discussed and interpreted the results. LL and SAV wrote the paper. All authors read, edited, and approved the final manuscript. LL, CMRL, GMB, NJS, and SAV conceptualized the project. SAV supervised the study.
S. A. V. is the co-founder of NemaLife Inc. that commercializes C. elegans assays. The remaining authors declare that they have no competing interests.
Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was partially supported by funding from the Cancer Prevention and Research Institute of Texas RP160806 (S.A.V), National Aeronautics and Space Administration NNX15AL16G (S.A.V), the Biotechnology and Biological Sciences Research Council (BB/N015894/1 to N.J.S), and National Institute of General Medical Sciences (R01 GM118534 to G.M.B.).
© The Author(s) 2021